1. High expression of transmembrane P24 trafficking protein 9 predicts poor prognosis in breast carcinoma
    Gaoda Ju et al, 2021, Bioengineered CrossRef
  2. Integrated bioinformatics analysis of microarray data from the GEO database to identify the candidate genes linked to poor prognosis in lung adenocarcinoma
    Xiaoling Liu et al, 2023, Technology and Health Care CrossRef
  3. Glycosylation in cancer as a source of biomarkers
    Sara Khorami-Sarvestani et al, 2024, Expert Review of Proteomics CrossRef
  4. COL15A1 interacts with P4HB to regulate the growth and malignancy of HepG2.2.15 cells
    Shuomin Wang et al, 2023, Biochemical and Biophysical Research Communications CrossRef
  5. Bone morphogenetic protein 1: a prognostic indicator and potential biomarker in three cancer types
    Ming Wang, 2024, American Journal of Translational Research CrossRef
  6. The Effect of N6-Methyladenosine Regulators and m6A Reader YTHDC1-Mediated N6-Methyladenosine Modification Is Involved in Oxidative Stress in Human Aortic Dissection
    Fanxing Yin et al, 2023, Oxidative Medicine and Cellular Longevity CrossRef
  7. Cytoskeleton regulator RNA expression on cancer-associated fibroblasts is associated with prognosis and immunotherapy response in bladder cancer
    Yucai Wu et al, 2023, Heliyon CrossRef
  8. Prognostic model development and molecular subtypes identification in bladder urothelial cancer by oxidative stress signatures
    Ying Dong et al, 2024, Aging CrossRef
  9. Current look at the most promising proteomic and glycomic biomarkers of bladder cancer
    Stefan Harsanyi et al, 2024, Journal of Cancer Research and Clinical Oncology CrossRef
  10. ERp44 Regulates the Proliferation, Migration, Invasion, and Apoptosis of Gastric Cancer Cells Via Activation of ER Stress
    Yongjing Tian et al, 2023, Biochemical Genetics CrossRef
  11. An Unfolded Protein Response Related Signature Could Robustly Predict Survival Outcomes and Closely Correlate With Response to Immunotherapy and Chemotherapy in Bladder Cancer
    Facai Zhang et al, 2021, Frontiers in Molecular Biosciences CrossRef
  12. A Short Overview on Therapeutic Biomarkers for Muscle Invasive Bladder Carcinoma
    Anika Sadaf et al, 2023, EMJ Urology CrossRef
  13. Abnormal ECA-Binding Membrane Glycans and Galactosylated CAT and P4HB in Lesion Tissues as Potential Biomarkers for Hepatocellular Carcinoma Diagnosis
    Ying Kong et al, 2022, Frontiers in Oncology CrossRef
  14. Construction of noninvasive prognostic model of bladder cancer patients based on urine proteomics and screening of natural compounds
    Shun Wan et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
  15. A meta-analysis and bioinformatics analysis of P4HB expression levels in the prognosis of cancer patients
    Feiyang Wang et al, 2023, Pathology - Research and Practice CrossRef
  16. Integrated Analysis and Identification of Critical RNA-Binding Proteins in Bladder Cancer
    Lijiang Gu et al, 2022, Cancers CrossRef
  17. Establishment of cancer-associated fibroblasts-related subtypes and prognostic index for prostate cancer through single-cell and bulk RNA transcriptome
    Youliang Qian et al, 2023, Scientific Reports CrossRef
  18. Expression, localization, and function of P4HB in the spermatogenesis of Chinese mitten crab (Eriocheir sinensis)
    Yulian Tang et al, 2023, PeerJ CrossRef
  19. Leveraging diverse cell-death patterns to predict the prognosis, immunotherapy and drug sensitivity of clear cell renal cell carcinoma
    Xi Zhang et al, 2023, Scientific Reports CrossRef
  20. A prognostic model for bladder cancer based on cytoskeleton-related genes
    Chunting Peng et al, 2023, Medicine CrossRef
  21. Establishment of novel ferroptosis-related prognostic subtypes correlating with immune dysfunction in prostate cancer patients
    Dechao Feng et al, 2024, Heliyon CrossRef